Literature DB >> 25103920

[Ryanodine receptor, calcium leak and arrhythmias].

Angélica Rueda1, David R de Alba-Aguayo2, Héctor H Valdivia3.   

Abstract

The participation of the ionic Ca(2+) release channel/ryanodine receptor in cardiac excitation-contraction coupling is well known since the late '80s, when various seminal papers communicated its purification for the first time and its identity with the "foot" structures located at the terminal cisternae of the sarcoplasmic reticulum. In addition to its main role as the Ca(2+) channel responsible for the transient Ca(2+) increase that activates the contractile machinery of the cardiomyocytes, the ryanodine receptor releases Ca(2+) during the relaxation phase of the cardiac cycle, giving rise to a diastolic Ca(2+) leak. In normal physiological conditions, diastolic Ca(2+) leak regulates the proper level of luminal Ca(2+), but in pathological conditions it participates in the generation of both, acquired and hereditary arrhythmias. Very recently, several groups have focused their efforts into the development of pharmacological tools to control the altered diastolic Ca(2+) leak via ryanodine receptors. In this review, we focus our interest on describing the participation of cardiac ryanodine receptor in the diastolic Ca(2+) leak under physiological or pathological conditions and also on the therapeutic approaches to control its undesired exacerbated activity during diastole.
Copyright © 2013 Instituto Nacional de Cardiología Ignacio Chávez. Published by Masson Doyma México S.A. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Arritmias; Calcium leak; Calcium sparks; Chispas de calcio; Corazón; Fuga de calcio; Heart; Mexico; México; Receptor de rianodina; Ryanodine receptor

Mesh:

Substances:

Year:  2014        PMID: 25103920     DOI: 10.1016/j.acmx.2013.12.008

Source DB:  PubMed          Journal:  Arch Cardiol Mex        ISSN: 1665-1731


  2 in total

Review 1.  TRPC Channels: Dysregulation and Ca2+ Mishandling in Ischemic Heart Disease.

Authors:  Débora Falcón; Isabel Galeano-Otero; Marta Martín-Bórnez; María Fernández-Velasco; Isabel Gallardo-Castillo; Juan A Rosado; Antonio Ordóñez; Tarik Smani
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

2.  Catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2 mutation: recreational cycling as a trigger of lethal arrhythmias.

Authors:  Antonio Gallegos-Cortez; Néstor Alonso-Ortiz; Erika Antunez-Argüellez; Teresa Villarreal-Molina; Armando Totomoch-Serra; Pedro Iturralde-Torres; Manlio F Márquez
Journal:  Arch Med Sci       Date:  2019-11-12       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.